Skip to main content

Table 2 Participant Characteristics after Matching

From: Quality of life among injectable and oral disease-modifying therapy users in the Pacific Northwest Multiple Sclerosis Registry

  

Stayer

Switcher

P value

  

124

64

 

Mean age (SD)

 

52.56 (10.51)

53.18 (11.96)

0.617

Sex % (n)

Female

87.9 (109)

88.7 (110)

1.000

 

Male

12.1 (15)

11.3 (14)

 

Race % (n)

White

92.7 (115)

90.3 (112)

0.017

 

Non-white

4.0 (5)

0.0 (0)

 
 

Unknown

3.2 (4)

9.7 (12)

 

Median disease duration [IQR]

 

11 [7, 15]

12 [7, 19]

0.038

PDDS % (n)

None or mild

44.4 (55)

51.6 (64)

0.306

 

Moderate to severe

55.6 (69)

48.4 (60)

 

Work status % (n)

Employed

52.9 (63)

55.7 (68)

0.435

 

Not Employed

47.1 (56)

44.3 (54)

 

Insurance % (n)

Public

31.5 (39)

21.0 (26)

0.114

 

Private

57.3 (71)

62.9 (78)

 
 

None/Other/Not Reported

11.3 (14)

16.1 (20)

 

Mean MSIS Physical Score at Time 1 (SD)

 

32.12 (11.67)

31.76 (10.09)

0.779

Mean MSIS Psychological Score at Time 1 (SD)

 

17.61 (6.62)

17.55 (5.66)

0.916

Median time on drug in months at Time 1 [IQR]

 

108.00

[50.50, 139.50]

97.50 [

65.00, 132.00]

0.955

  1. [SD standard deviation, IQR Interquartile range, PDDS Patient Determined Disease Steps, MSIS Multiple Sclerosis Impact Scale]